Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.2512
+0.0107 (4.45%)
At close: Jul 24, 2025, 4:00 PM
0.2524
+0.0012 (0.48%)
After-hours: Jul 24, 2025, 7:59 PM EDT

Processa Pharmaceuticals Stock Forecast

PCSA's stock price has decreased by -85.44% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Processa Pharmaceuticals stock has a target of 2, which predicts a 696.18% increase from the current stock price of 0.25.

Price Target: $2 (+696.18%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$2.00$2.00$2.00$2.00
Change+696.18%+696.18%+696.18%+696.18%

Analyst Ratings

According to 1 stock analyst, the rating for Processa Pharmaceuticals is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy111111
Buy111100
Hold000000
Sell000000
Strong Sell000000
Total222211

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$6$2
Strong BuyMaintains$6$2+696.18%Jun 30, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$6
Strong BuyReiterates$6+2,288.54%Dec 5, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$6
Strong BuyReiterates$6+2,288.54%Oct 3, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$6
Strong BuyReiterates$6+2,288.54%Aug 20, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$8$6
Strong BuyMaintains$8$6+2,288.54%Aug 19, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.55
from -3.87
EPS Next Year
-0.20
from -0.55
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2028FY 2029
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2028Dec 31, 2029
Revenue
--54.14M126.39M
Revenue Growth
---133.46%----
EPS
-50.77-14.92-34.05-8.48-3.87-0.55-0.20-
EPS Growth
--------
Forward PE
--------
No. Analysts
-----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue2025202620282029
Highn/an/a55.7M
Avgn/an/a54.1M
Lown/an/a52.0M

Revenue Growth

Revenue Growth2025202620282029
High---
Avg---
Low---

EPS Forecast

EPS20252026
High-0.57-0.21
Avg-0.55-0.20
Low-0.53-0.20

EPS Growth

EPS Growth20252026
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.